Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.
Hurkmans DP, Kuipers ME, Smit J, van Marion R, Mathijssen RHJ, Postmus PE, Hiemstra PS, Aerts JGJV, von der Thüsen JH, van der Burg SH. Hurkmans DP, et al. Among authors: van der burg sh, van marion r. Cancer Immunol Immunother. 2020 May;69(5):771-777. doi: 10.1007/s00262-020-02506-x. Epub 2020 Feb 12. Cancer Immunol Immunother. 2020. PMID: 32047958 Free PMC article.
Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
Ernst SM, Uzun S, Paats MS, van Marion R, Atmodimedjo PN, de Jonge E, van Schaik RHN, Aerts JGJV, von der Thüsen JH, Dubbink HJ, Dingemans AC. Ernst SM, et al. Among authors: van marion r. JCO Precis Oncol. 2023 Sep;7:e2300451. doi: 10.1200/PO.23.00451. JCO Precis Oncol. 2023. PMID: 38096473 Free PMC article.
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib.
Ernst SM, van Marion R, Atmodimedjo PN, de Jonge E, Mathijssen RHJ, Paats MS, de Bruijn P, Koolen SL, von der Thüsen JH, Aerts JGJV, van Schaik RHN, Dubbink HJ, Dingemans AC. Ernst SM, et al. Among authors: van marion r. J Thorac Oncol. 2024 Jul;19(7):995-1006. doi: 10.1016/j.jtho.2024.04.007. Epub 2024 Apr 12. J Thorac Oncol. 2024. PMID: 38615940 Free article.
Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen.
Jansen MP, Martens JW, Helmijr JC, Beaufort CM, van Marion R, Krol NM, Monkhorst K, Trapman-Jansen AM, Meijer-van Gelder ME, Weerts MJ, Ramirez-Ardila DE, Dubbink HJ, Foekens JA, Sleijfer S, Berns EM. Jansen MP, et al. Among authors: van marion r. Oncotarget. 2016 Jul 12;7(28):43412-43418. doi: 10.18632/oncotarget.9727. Oncotarget. 2016. PMID: 27270325 Free PMC article.
Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.
Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, Nishihira T, Tselepis C, Hainaut P, Lowe AW, Beverloo BH, van Dekken H, Tilanus HW, Dinjens WN. Boonstra JJ, et al. Among authors: van dekken h, van der velden aw, van marion r. Cancer Res. 2007 Sep 1;67(17):7996-8001. doi: 10.1158/0008-5472.CAN-07-2064. Cancer Res. 2007. PMID: 17804709
56 results